ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 84 filers reported holding ATHIRA PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,690,501 | -31.5% | 4,797,278 | 0.0% | 0.32% | -21.2% |
| Q2 2023 | $14,151,970 | +18.0% | 4,797,278 | 0.0% | 0.41% | +15.8% |
| Q1 2023 | $11,993,195 | -21.1% | 4,797,278 | 0.0% | 0.35% | -17.1% |
| Q4 2022 | $15,207,371 | +6.7% | 4,797,278 | 0.0% | 0.43% | +3.1% |
| Q3 2022 | $14,248,000 | -2.6% | 4,797,278 | 0.0% | 0.41% | -9.6% |
| Q2 2022 | $14,632,000 | -68.4% | 4,797,278 | +40.0% | 0.46% | -50.5% |
| Q1 2022 | $46,250,000 | -48.2% | 3,425,916 | -50.0% | 0.93% | +34.4% |
| Q4 2021 | $89,280,000 | +177.8% | 6,851,832 | +100.0% | 0.69% | +47.5% |
| Q3 2021 | $32,135,000 | -54.2% | 3,425,916 | -50.0% | 0.47% | +2.4% |
| Q2 2021 | $70,162,000 | +11.3% | 6,851,832 | +100.0% | 0.46% | -42.8% |
| Q1 2021 | $63,037,000 | -40.9% | 3,425,916 | +10.0% | 0.80% | -30.4% |
| Q4 2020 | $106,682,000 | +85.5% | 3,114,805 | 0.0% | 1.14% | +36.5% |
| Q3 2020 | $57,499,000 | – | 3,114,805 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |